Mo1550: RISANKIZUMAB DECREASES ALKALINE PHOSPHATASE LEVELS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND COMORBID INFLAMMATORY BOWEL DISEASES
Sarah Khan, Katherine Falloon, Laura Sahyoun(Cornell University), Dana J. Lukin(Cornell University), Zehra Naseem, Erin Causey, Olumuyiwa Awoniyi, Florian Rieder(Cleveland Clinic)
Cited by 0
Related Papers
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
|Journal of Crohn s and Colitis|2018|464
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
|Nature Reviews Gastroenterology & Hepatology|2023|248
Real-Time Shear Wave Ultrasound Elastography Differentiates Fibrotic from Inflammatory Strictures in Patients with Crohn’s Disease
|Inflammatory Bowel Diseases|2018|92